Ocean-Alkalinity Scale Board Adviser

The mandate

The committee repeatedly asks which evidence from controlled coastal trials justifies larger, longer or more dispersed deployment. Science teams emphasise chemistry, field operations emphasises controllable release, commercial teams count prospective tonnes and communities ask how uncertainty and reversibility will be governed. Measurement and ecological baselines mature at different speeds. The adviser’s standing question is how the board stages scale without turning scientific hypothesis into premature environmental or commercial assurance.

The cadence is four days monthly: one evidence review, one deployment-and-capital challenge, chair preparation and either committee attendance or a field visit. Six committee meetings and four controlled laboratory or coastal reviews are included. A material ecological or deployment event receives a response within twenty-four hours. Live field direction, scientific interpretation, permit decisions, credit validation and community representation remain with qualified and authorised parties.

The term lasts ten months through two trial-result gates and the next deployment-capital decision. One two-month renewal may occur if a named monitoring period remains incomplete and conflicts are refreshed. The adviser concludes with a scale-stage framework, decision history, ecological dependency map and evidence triggers for continuation, constraint, reversal or stop. The independent chair decides renewal after management demonstrates use without continuing dependence.

The adviser has no line authority, executive responsibility, scientific approval, field command or board vote. Scientists interpret results, operators execute approved plans, authorities determine permissions and directors sanction capital. The adviser may challenge causal claims, press for controls and recommend delay, but cannot prescribe dose, select sites, certify removal, approve monitoring, direct vessels, determine ecological acceptability or issue public assurance.

Relationships involving competing removal developers, minerals providers, vessel operators, laboratories, registries, buyers, research institutions, governments or investors require disclosure. A current role for a live supplier or project counterparty triggers recusal. Other non-conflicting appointments may continue within cadence. Compensation is independent of tonnes claimed, credits issued, deployment volume, permit success, funding, valuation or supplier selection.

Why the board wants this voice

The venture has distinguished scientists and experienced investors, but nobody on the board has repeatedly governed environmental technology from experiment into controlled field operation. Commercial pressure can make uncertainty sound like delay rather than information. Independent deployment judgment helps directors define reversible steps and keep scientific, operational and social licence evidence separate but connected.

What you will own

• Press management to separate measured chemistry, inferred removal, ecological observation, model projection and commercial claim across sites, seasons, methods and credit vintages.
• Test scale proposals across material source, dosing control, ocean conditions, monitoring duration, vessel capacity and reversibility.
• Challenge baselines and counterfactuals where natural variability or spatial movement weakens causal interpretation.
• Examine community, fishing, permitting and emergency interfaces before field footprint or duration expands.
• Shape board gates for trial, extended monitoring, site expansion, commercial commitment and stop.
• Maintain independent records of uncertainty, failed hypotheses, conflicts, dissent and evidence expiry.
• Leave the committee a repeatable deployment review linked to scientific and operating proof.

Candidate qualifications

• Has governed marine science, environmental remediation or comparable field technology through staged deployment, uncertain measurement, ecological challenge, coastal community scrutiny and external assurance review.
• Can evidence a scale decision slowed because ecological or measurement uncertainty remained material.
• Understands field trials, baselines, monitoring, material custody, vessel operations, permits and community interfaces.
• Has challenged scientific and commercial founders without making technical conclusions personally.
• Can distinguish observed change, causal attribution, durable outcome and creditable commercial claim.
• Is independent of relevant developers, laboratories, vessel providers, registries, buyers and investors.

Non-negotiables

• Can attend six Lisbon committee meetings and complete four controlled field or laboratory evidence visits.
• Will not certify removal, ecology, monitoring, permits, credits or public claims through this appointment.
• Brings direct environmental field-deployment governance; carbon-market advocacy alone is insufficient.
• Will disclose developer, supplier, laboratory, registry, buyer and investor interests before reviewing trials.

1. 49 words maximum. Which field-scale assumption failed when environmental variability exceeded the controlled trial range?
2. 49 words maximum. What developer, laboratory, vessel, registry or buyer interests would this board need disclosed?
3. 49 words maximum. When have you recommended extended monitoring instead of a larger deployment?